In this study, an orthotopic HCC model (via hydrodynamic injection of Akt/Nras plasmids) and a subcutaneous tumor model (using c-Met/sgPten cells) were established to evaluate the therapeutic effects of HQF on HCC. The gene discussed is MET; the disease is hepatocellular carcinoma.